Science Explorer Back to mapMap
Discussion
Company · Panama City · Panama

VaxTrials (Panama)

Research works
2
▲ 183% vs 2018-21
Citations
35
14.8 per fractional work
Top-10% rate
3.9%
all institutions 10.0%
Open access
100%
world 40%
International
58%
world 18%

Not ranked overall: VaxTrials (Panama) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does VaxTrials (Panama) work in?

In all years, 88% of research at VaxTrials (Panama) is in Health Sciences, 8% in Social Sciences. Its largest fields are Medicine (83%), Mathematics (4%), Health Professions (4%). It does 1.4× the world's share of Health Sciences.

Physical Sciences4%Health Sciences88%Social Sciences8%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 5 fields, with their numbers
    1. Medicine283.3%
    2. Health Professions04.2%
    1. Economics, Econometrics and Finance04.2%
    2. Social Sciences04.2%
    1. Mathematics04.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 0.37× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 5.42× its world share, 0 worksImmunology and Micro…Mathematics: 11.14× its world share, 0 worksMathematicsHealth Professions: 3.75× its world share, 0 worksHealth ProfessionsMedicine: 2.55× its world share, 0 worksMedicineEconomics, Econometrics and Finance: 6.12× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.59× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Mathematics, 11.1×. Every wedge is a field page.

All 7 fields, with their numbers
  1. Mathematics11.14×0 works
  2. Economics, Econometrics and Finance6.12×0 works
  3. Immunology and Microbiology5.42×0 works
  4. Health Professions3.75×0 works
  5. Medicine2.55×0 works
  6. Social Sciences0.59×0 works
  7. Biochemistry, Genetics and Molecular Biology0.37×0 works

What are the most cited papers from VaxTrials (Panama)?

The most cited paper from VaxTrials (Panama) is "Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial" (Edwin Jose Asturias, Ananda Sankar Bandyopadhyay, Steve G Self et al., 2016), with 83 citations. Next come "Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials" (81) and "Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study" (77).

Most cited papers
#PaperReleasedCitations
1 Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial Edwin Jose Asturias, Ananda Sankar Bandyopadhyay, Steve G Self et al. · The Lancet Open access 21 May 2016 83
2 Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials Xavier Sáez‐Llorens, Ananda Sankar Bandyopadhyay, Christopher Gast et al. · The Lancet Open access 9 Dec 2020 81
3 Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study Miguel O’Ryan, Ananda Sankar Bandyopadhyay, Rodolfo Villena et al. · The Lancet Infectious Diseases Open access 26 Aug 2015 77
4 Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil Sue Ann Costa Clemens et al. · Nature Communications Open access128 authors 6 Oct 2021 54
5 Immunogenicity and safety of a novel monovalent high-dose inactivated poliovirus type 2 vaccine in infants: a comparative, observer-blind, randomised, controlled trial Xavier Sáez‐Llorens, Ralf L. Clemens, Geert G Leroux-Roels et al. · The Lancet Infectious Diseases Open access 21 Dec 2015 44
All 10 most cited papers, with filters and sorting

Which research topics does VaxTrials (Panama) publish most on?

By volume in 2022-now: Viral gastroenteritis research and epidemiology, Respiratory viral infections research, Viral Infections and Immunology Research and Pneumonia and Respiratory Infections.

  1. 1 Viral gastroenteritis research and epidemiology Infectious Diseases 0 works
  2. 2 Respiratory viral infections research Epidemiology 0 works
  3. 3 Viral Infections and Immunology Research Cardiology and Cardiovascular Medicine 0 works
  4. 4 Pneumonia and Respiratory Infections Epidemiology 0 works
  5. 5 Statistical Methods in Clinical Trials Statistics and Probability 0 works
  6. 6 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
  7. 7 Pediatric health and respiratory diseases Emergency Medical Services 0 works
  8. 8 Chronic Obstructive Pulmonary Disease (COPD) Research Pulmonary and Respiratory Medicine 0 works
  9. 9 Bacterial Infections and Vaccines Microbiology 0 works
  10. 10 Vaccine Coverage and Hesitancy Health 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available100.0%

World: 40% of research is openly available.

with international co-authors57.7%domestic only42.3%

World: 18% is written across borders.

How has VaxTrials (Panama)'s research output changed?

Output in 2022-2025 was 183% higher than in 2018-2021.

still counting20202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Panama City

All research institutions in Panama City

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about VaxTrials (Panama). Posts are plain text and can be reported.